Mitral valve disease—morphology and mechanisms
Open accessThe DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Abstract
Mitral valve disease is a frequent cause of heart failure and death. Emerging evidence indicates that the mitral valve is not a passive structure, but—even in adult life—remains dynamic and accessible for treatment. This concept motivates efforts to reduce the clinical progression of mitral valve disease through early detection and modification of underlying mechanisms. Discoveries of genetic mutations causing mitral valve elongation and prolapse have revealed that growth factor signalling and cell migration pathways are regulated by structural molecules in ways that can be modified to limit progression from developmental defects to valve degeneration with clinical complications. Mitral valve enlargement can determine left ventricular outflow tract obstruction in hypertrophic cardiomyopathy, and might be stimulated by potentially modifiable biological valvular–ventricular interactions. Mitral valve plasticity also allows adaptive growth in response to ventricular remodelling. However, adverse cellular and mechanobiological processes create relative leaflet deficiency in the ischaemic setting, leading to mitral regurgitation with increased heart failure and mortality. Our approach, which bridges clinicians and basic scientists, enables the correlation of observed disease with cellular and molecular mechanisms, leading to the discovery of new opportunities for improving the natural history of mitral valve disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881 · cited 1×
“1,2 Structural deficiencies in the mitral valve and secondary changes induced by abnormal ventricular size and deforma tion are implicated in the development of these valvu lar lesions.”
BackgroundMarfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
Dietz, H. C., Cutting, C. R., Pyeritz, R. E., Maslen, C. L., Sakai, L. Y., Corson, G. M., Puffenberger, E. G., Hamosh, A., Nanthakumar, E. J., Curristin, S. M., et al. (1991) · Nature · doi:10.1038/352337a0 · Cited by 2,070
Self-citationLoeys, B. L., Chen, J., Neptune, E. R., Judge, D. P., Podowski, M., Holm, T., Meyers, J., Leitch, C. C., Katsanis, N., Sharifi, N., et al. (2005) · Nature Genetics · doi:10.1038/ng1511 · Cited by 1,795
Self-citationLosartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Self-citationLancellotti, P., Tribouilloy, C., Hagendorff, A., Popescu, B. A., Edvardsen, T., Pierard, L. A., Badano, L., Zamorano, J. L., & On behalf of the Scientific Document Committee of the European Association of Cardiovascular Imaging: Thor Edvardsen, O. B. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jet105 · Cited by 1,734
Heritable Disorders of Connective Tissue
(1960) · Postgraduate Medical Journal · doi:10.1136/pgmj.36.415.346 · Cited by 1,527
Grigioni, F., Enriquez-Sarano, M., Zehr, K. J., Bailey, K. R., & Tajik, A. J. (2001) · Circulation · doi:10.1161/01.cir.103.13.1759 · Cited by 1,429
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
Neptune, E. R., Frischmeyer, P. A., Arking, D. E., Myers, L., Bunton, T. E., Gayraud, B., Ramirez, F., Sakai, L. Y., & Dietz, H. C. (2003) · Nature Genetics · doi:10.1038/ng1116 · Cited by 1,404
Self-citationMaron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Prevalence and Clinical Outcome of Mitral-Valve Prolapse
Freed, L. A., Levy, D., Levine, R. A., Larson, M. G., Evans, J. C., Fuller, D. L., Lehman, B., & Benjamin, E. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410101 · Cited by 1,169
Self-citation
Cited by
Atrial Functional Mitral Regurgitation
Deferm, S., Bertrand, P. B., Verbrugge, F. H., Verhaert, D., Rega, F., Thomas, J. D., & Vandervoort, P. M. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.061 · Cited by 396
Morphofunctional Abnormalities of Mitral Annulus and Arrhythmic Mitral Valve Prolapse
Perazzolo Marra, M., Basso, C., De Lazzari, M., Rizzo, S., Cipriani, A., Giorgi, B., Lacognata, C., Rigato, I., Migliore, F., Pilichou, K., et al. (2016) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005030 · Cited by 373
Connective tissue growth factor (CTGF) from basics to clinics
Ramazani, Y., Knops, N., Elmonem, M. A., Nguyen, T. Q., Arcolino, F. O., van den Heuvel, L., Levtchenko, E., Kuypers, D., & Goldschmeding, R. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.007 · Cited by 329
Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death
Basso, C., Iliceto, S., Thiene, G., & Perazzolo Marra, M. (2019) · Circulation · doi:10.1161/circulationaha.118.034075 · Cited by 290
The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy
Sherrid, M. V., Balaram, S., Kim, B., Axel, L., & Swistel, D. G. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.071 · Cited by 276
Region and cell-type resolved quantitative proteomic map of the human heart
Doll, S., Dreßen, M., Geyer, P. E., Itzhak, D. N., Braun, C., Doppler, S. A., Meier, F., Deutsch, M.-A., Lahm, H., Lange, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01747-2 · Cited by 270
Immune Mechanisms in Heart Failure
Zhang, Y., Bauersachs, J., & Langer, H. F. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.942 · Cited by 262
Formate metabolism in health and disease
Pietzke, M., Meiser, J., & Vazquez, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.012 · Cited by 218
“Mitral valve insufficiency is a cardiovascular disorder that can cause heart failure and death [141].”
BackgroundFollistatin-like 1 in development and human diseases
Mattiotti, A., Prakash, S., Barnett, P., & van den Hoff, M. J. B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2805-0 · Cited by 168
Hemodynamic Forces Sculpt Developing Heart Valves through a KLF2-WNT9B Paracrine Signaling Axis
Goddard, L. M., Duchemin, A.-L., Ramalingan, H., Wu, B., Chen, M., Bamezai, S., Yang, J., Li, L., Morley, M. P., Wang, T., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.09.023 · Cited by 156
“…to specific genetic mutations (e.g., in NOTCH1, TBX5, GATA4, TBX20, LMCD1, TNS1, and DCHS1) (Dina et al., 2015; Durst et al., 2015; Garg et al., 2005; Richards and Garg, 2010; Theodoris et al., 2015), the majority have no clearly definable genetic or environmental cause (Levine et al., 2015).”
Future prospects in the tissue engineering of heart valves: a focus on the role of stem cells
Albert, B. J., & Butcher, J. T. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2214313 · Cited by 8
Self-citation
Metadata
- Authors
- Levine, R. A., Hagége, A. A., Judge, D. P., Padala, M., Dal-Bianco, J. P., Aikawa, E., Beaudoin, J., Bischoff, J., Bouatia-Naji, N., Bruneval, P., Butcher, J. T., Carpentier, A., Chaput, M., Chester, A. H., Clusel, C., Delling, F. N., Dietz, H. C., Dina, C., Durst, R., Fernandez-Friera, L., Handschumacher, M. D., Jensen, M. O., Jeunemaitre, X. P., Marec, H. L., Tourneau, T. L., Markwald, R. R., Mérot, J., Messas, E., Milan, D. P., Neri, T., Norris, R. A., Peal, D., Perrocheau, M., Probst, V., Pucéat, M., Rosenthal, N., Solis, J., Schott, J.-J., Schwammenthal, E., Slaugenhaupt, S. A., Song, J.-K., Yacoub, M. H., & for the Leducq Mitral Transatlantic Network
- Venue
- Nature Reviews Cardiology
- Published
- 2015-10-20
- Volume
- 12
- Issue
- 12
- Pages
- 689-710
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W1754892555
- Cited by
- 386
- References
- 206
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.